Paroxysmal Dyskinesias

Abstract

Paroxysmal dyskinesias represent a group of uncommon movement disorders that are characterized by episodes of abnormal movements arising from a baseline of normal or nearly normal movement. Recent advances in the genetics of these disorders have helped provide some unification of classification schemes and better understanding. Three major phenotypes constitute the paroxysmal dyskinesias. Paroxysmal kinesigenic dyskinesia is characterized by very brief spells (seconds) that are triggered by sudden movement. Paroxysmal nonkinesigenic dyskinesia (PNKD) is characterized by longer lasting spells (minutes to hours) that may be precipitated by caffeine or alcohol consumption. Paroxysmal exertional dyskinesia is characterized by spells brought on by sustained exertion. The approach to treatment continues to be based on the phenotype more than the genotype.

Keywords

dystonia - episodic dyskinesia - chorea

• References

• 1 Bruno MK, Hallett M, Gwinn-Hardy K , et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004; 63 (12) 2280-2287
• 2 Bruno MK, Lee HY, Auburger GWJ , et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007; 68 (21) 1782-1789
• 3 Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38 (4) 571-579
• 4 Erro R, Sheerin U-M, Bhatia KP. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Mov Disord 2014; 29 (9) 1108-1116
• 5 Goodenough DJ, Fariello RG, Annis BL, Chun RW. Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol 1978; 35 (12) 827-831
• 6 Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol 2003; 10 (1) 68-79
• 7 Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 1967; 17 (7) 680-690
• 8 Chen WJ, Lin Y, Xiong ZQ , et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43 (12) 1252-1255
• 9 Wang JL, Cao L, Li XH , et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011; 134 (Pt 12) 3493-3501
• 10 Lee HY, Huang Y, Bruneau N , et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Reports 2012; 1 (1) 2-12
• 11 Cloarec R, Bruneau N, Rudolf G , et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012; 79 (21) 2097-2103
• 12 Gardiner AR, Bhatia KP, Stamelou M , et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012; 79 (21) 2115-2121
• 13 Silveira-Moriyama L, Gardiner AR, Meyer E , et al. Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations. Dev Med Child Neurol 2013; 55 (4) 327-334
• 14 Scheffer IE, Grinton BE, Heron SE , et al. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology 2012; 79 (21) 2104-2108
• 15 Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord 2002; 17 (4) 726-734
• 16 Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol 1984; 41 (7) 747-750
• 17 Rosen JA. Paroxysmal choreoathetosis associated with perinatal hypoxic encephalopathy. Arch Neurol 1964; 11: 385-387
• 18 Kato H, Kobayashi K, Kohari S, Okita N, Iijima K. Paroxysmal kinesigenic choreoathetosis and paroxysmal dystonic choreoathetosis in a patient with familial idiopathic hypoparathyroidism. Tohoku J Exp Med 1987; 151 (2) 233-239
• 19 Dure IV LS, Mussell HG. Paroxysmal dyskinesia in a patient with pseudohypoparathyroidism. Mov Disord 1998; 13 (4) 746-748
• 20 Mahmud FH, Linglart A, Bastepe M, Jüppner H, Lteif AN. Molecular diagnosis of pseudohypoparathyroidism type Ib in a family with presumed paroxysmal dyskinesia. Pediatrics 2005; 115 (2) e242-e244
• 21 Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN. Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia. Pediatr Neurol 2010; 43 (1) 46-48
• 22 Brockmann K, Dumitrescu AM, Best TT, Hanefeld F, Refetoff S. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. J Neurol 2005; 252 (6) 663-666
• 23 Gay CT, Ryan SG. Paroxysmal kinesigenic dystonia after methylphenidate administration. J Child Neurol 1994; 9 (1) 45-46
• 24 Li HF, Chen WJ, Ni W , et al. PRRT2 mutation correlated with phenotype of paroxysmal kinesigenic dyskinesia and drug response. Neurology 2013; 80 (16) 1534-1535
• 25 Chatterjee A, Louis ED, Frucht S. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis. Mov Disord 2002; 17 (3) 614-615
• 26 Chudnow RS, Mimbela RA, Owen DB, Roach ES. Gabapentin for familial paroxysmal dystonic choreoathetosis. Neurology 1997; 49 (5) 1441-1442
• 27 Tsao CY. Effective treatment with oxcarbazepine in paroxysmal kinesigenic choreoathetosis. J Child Neurol 2004; 19 (4) 300-301
• 28 Uberall MA, Wenzel D. Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis. Dev Med Child Neurol 2000; 42 (10) 699-700
• 29 Huang YG, Chen YC, Du F , et al. Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord 2005; 20 (1) 75-77
• 30 Homan RW, Vasko MR, Blaw M. Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis. Neurology 1980; 30 (6) 673-676
• 31 Wein T, Andermann F, Silver K , et al. Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine. Neurology 1996; 47 (4) 1104-1106
• 32 Yang Y, Su Y, Guo Y , et al. Oxcarbazepine versus carbamazepine in the treatment of paroxysmal kinesigenic dyskinesia. Int J Neurosci 2012; 122 (12) 719-722
• 33 Loong SC, Ong YY. Paroxysmal kinesigenic choreoathetosis. Report of a case relieved by L-dopa. J Neurol Neurosurg Psychiatry 1973; 36 (6) 921-924
• 34 Forssman H. Hereditary disorder characterized by attacks of muscular contractions, induced by alcohol amongst other factors. Acta Med Scand 1961; 170: 517-533
• 35 Mount LA, Reback S. Familial paroxysmal choreoathetosis. Arch Neurol Psychiatry 1940; 44: 841-847
• 36 Rainier S, Thomas D, Tokarz D , et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol 2004; 61 (7) 1025-1029
• 37 Mayeux R, Fahn S. Paroxysmal dystonic choreoathetosis in a patient with familial ataxia. Neurology 1982; 32 (10) 1184-1186
• 38 Byrne E, White O, Cook M. Familial dystonic choreoathetosis with myokymia; a sleep responsive disorder. J Neurol Neurosurg Psychiatry 1991; 54 (12) 1090-1092
• 39 Kurlan R, Behr J, Medved L, Shoulson I. Familial paroxysmal dystonic choreoathetosis: a family study. Mov Disord 1987; 2 (3) 187-192
• 40 Lee HY, Xu Y, Huang Y , et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004; 13 (24) 3161-3170
• 41 Hayashi T, Shibamoto T. Analysis of methylglyoxal in foods and beverages. J Agric Food Chem 1985; 33: 1090-1093
• 42 Shen Y, Lee HY, Rawson J , et al. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum Mol Genet 2011; 20 (12) 2322-2332
• 43 Du W, Bautista JF, Yang H , et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 2005; 37 (7) 733-738
• 44 Temudo T, Martins E, Poças F, Cruz R, Vilarinho L. Maple syrup disease presenting as paroxysmal dystonia. Ann Neurol 2004; 56 (5) 749-750
• 45 Zorzi G, Castellotti B, Zibordi F, Gellera C, Nardocci N. Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology 2008; 71 (2) 146-148
• 46 Nygaard TG. Dopa-responsive dystonia. Curr Opin Neurol 1995; 8 (4) 310-313
• 47 Dooley JM, Brna PM. Sublingual lorazepam in the treatment of familial paroxysmal nonkinesigenic dyskinesia. Pediatr Neurol 2004; 30 (5) 365-366
• 48 Kurlan R, Shoulson I. Familial paroxysmal dystonic choreoathetosis and response to alternate-day oxazepam therapy. Ann Neurol 1983; 13 (4) 456-457
• 49 Przuntek H, Monninger P. Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type. J Neurol 1983; 230 (3) 163-169
• 50 Alemdar M, Iseri P, Selekler M, Komsuoğlu SS. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol 2007; 30 (4) 241-244
• 51 Micheli F, Fernandez Pardal M, de Arbelaiz R, Lehkuniec E, Giannaula R. Paroxysmal dystonia responsive to anticholinergic drugs. Clin Neuropharmacol 1987; 10 (4) 365-369
• 52 Loher TJ, Krauss JK, Burgunder JM, Taub E, Siegfried J. Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia. Neurology 2001; 56 (2) 268-270
• 53 Yamada K, Goto S, Soyama N , et al. Complete suppression of paroxysmal nonkinesigenic dyskinesia by globus pallidus internus pallidal stimulation. Mov Disord 2006; 21 (4) 576-579
• 54 Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977; 2 (4) 285-293
• 55 Plant GT, Williams AC, Earl CJ, Marsden CD. Familial paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1984; 47 (3) 275-279
• 56 Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD. Paroxysmal exercise-induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord 1997; 12 (6) 1007-1012
• 57 Weber YG, Storch A, Wuttke TV , et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008; 118 (6) 2157-2168
• 58 Weber YG, Kamm C, Suls A , et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 2011; 77 (10) 959-964
• 59 Auburger G, Ratzlaff T, Lunkes A , et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996; 31 (1) 90-94
• 60 Münchau A, Valente EM, Shahidi GA , et al. A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. J Neurol Neurosurg Psychiatry 2000; 68 (5) 609-614
• 61 Kamm C, Mayer P, Sharma M, Niemann G, Gasser T. New family with paroxysmal exercise-induced dystonia and epilepsy. Mov Disord 2007; 22 (6) 873-877
• 62 Lim EC, Wong YS. Post-traumatic paroxysmal exercise-induced dystonia: case report and review of the literature. Parkinsonism Relat Disord 2003; 9 (6) 371-373
• 63 Alter AS, Engelstad K, Hinton VJ , et al. Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol 2015; 30 (2) 160-169
• 64 Urbizu A, Cuenca-León E, Raspall-Chaure M , et al. Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation. J Neurol Sci 2010; 295 (1-2) 110-113
• 65 Ramm-Pettersen A, Nakken KO, Skogseid IM , et al. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 2013; 55 (5) 440-447
• 66 Leen WG, Mewasingh L, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA. Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet. Mov Disord 2013; 28 (10) 1439-1442